Rajni Agarwal-Hashmi

Associate Professor of Pediatrics (Stem Cell Transplantation) at the Lucile Salter Packard Children's Hospital

Professional Education

Board Certification: Pediatrics, American Board of Pediatrics (1996)

Residency: Children's Hospital Medical Center (1995) OH

Residency: MGM Medical College (1983) India

Medical Education: MGM Medical College (1983) India

Internship: MGM Medical College (1981) India

MD, Indore University, Pediatrics (1983)

M.B.B.S, Indore University (1980)

Honors & Awards

President's award, Best Woman Candidate in India in Medical School Examinations (1979)

Administrative Appointments

Section chief, Pediatric Stem Cell Transplantation (2010 - Present)

Associate chief, Pediaric hematology/oncology/stem cell transplantation (2010 - Present)

Clinical Director, Pediatric Stem Cell Transplant (2008 - Present)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Pathological evidence of Wolman's disease following hematopoietic stem cell transplantation despite correction of lysosomal acid lipase activity
Gramatges, M. M., Dvorak, C. C., Regula, D. P., Enns, G. M., Weinberg, K., & Agarwal, R. (2009). Pathological evidence of Wolman's disease following hematopoietic stem cell transplantation despite correction of lysosomal acid lipase activity. BONE MARROW TRANSPLANTATION, 44(7), 449-450.

Nontuberculous Mycobacteria Infections in Immunocompromised Patients Single Institution Experience
Wei, M. C., Banaei, N., Yakrus, M. A., Stoll, T., Gutierrez, K. M., & Agarwal, R. (2009). Nontuberculous Mycobacteria Infections in Immunocompromised Patients Single Institution Experience. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 31(8), 556-560.

High-dose chemotherapy followed by stem cell rescue for high-risk germ cell tumors: the Stanford experience
Agarwal, R., Dvorak, C. C., Stockerl-Goldstein, K. E., Johnston, L., & Srinivas, S. (2009). High-dose chemotherapy followed by stem cell rescue for high-risk germ cell tumors: the Stanford experience. BONE MARROW TRANSPLANTATION, 43(7), 547-552.

Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia
Dvorak, C. C., Agarwal, R., Dahl, G. V., Gregory, J. J., & Feusner, J. H. (2008). Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 14(7), 824-830.

SAFETY OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN LESS THAN THREE YEARS OF AGE
Dvorak, C. C., Wright, N. B., Wong, W. B., Kristovich, K. M., Matthews, E. W., & Agarwal, R. (2008). SAFETY OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN LESS THAN THREE YEARS OF AGE. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 25(8), 705-722.

Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy
Deeg, H. J., O'Donnell, M., Tolar, J., Agarwal, R., Harris, R. E., & Storer, B. (2006). Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. BLOOD, 108(5), 1485-1491.

Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus
Dvorak, C. C., Callard, E., & Agarwal, R. (2006). Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus. BONE MARROW TRANSPLANTATION, 38(3), 253-254.

Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation
Dvorak, C. C., Steinbach, W. J., Brown, J. My., & Agarwal, R. (2005). Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation. BONE MARROW TRANSPLANTATION, 36(7), 621-629.

High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: Results and prognostic indices
Lieskovsky, Y. E., Donaldson, S. S., Torres, M. A., Wong, R. M., Amylon, M. D., & Agarwal, R. (2004). High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: Results and prognostic indices. JOURNAL OF CLINICAL ONCOLOGY, 22(22), 4532-4540.

Continuous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy
DiCarlo, J. V., Alexander, S. R., Agarwal, R., & Schiffman, J. D. (2003). Continuous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 25(10), 801-805.

Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation
Morris, J. D., Harris, R. E., Hashmi, R., SAMBRANO, J. E., Gruppo, R. A., & Morris, C. L. (1997). Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation. BONE MARROW TRANSPLANTATION, 20(10), 871-878.

Retroviral transduction of CD34-enriched hematopoietic progenitor cells under serum-free conditions
Sekhar, M., Kotani, H., Doren, S., Agarwal, R., McGarrity, G., & DUNBAR, C. E. (1996). Retroviral transduction of CD34-enriched hematopoietic progenitor cells under serum-free conditions. HUMAN GENE THERAPY, 7(1), 33-38.

LONG-TERM CULTURE OF CHRONIC MYELOGENOUS LEUKEMIA MARROW-CELLS ON STEM-CELL FACTOR-DEFICIENT STROMA FAVORS BENIGN PROGENITORS
Agarwal, R., Doren, S., Hicks, B., & DUNBAR, C. E. (1995). LONG-TERM CULTURE OF CHRONIC MYELOGENOUS LEUKEMIA MARROW-CELLS ON STEM-CELL FACTOR-DEFICIENT STROMA FAVORS BENIGN PROGENITORS. BLOOD, 85(5), 1306-1312.

SPLENIC AND HEPATIC PELIOSIS - MR FINDINGS
MAVES, C. K., CARON, K. H., Bisset, G. S., & Agarwal, R. (1992). SPLENIC AND HEPATIC PELIOSIS - MR FINDINGS. AMERICAN JOURNAL OF ROENTGENOLOGY, 158(1), 75-76.